P1.03-17 Functional Mechanism of GLDC Gene Alternative Splicing in Non-Small Cell Lung Cancer Y. Yuan, K. Ma The First Hospital of Jinlin University, Changchun/CN Background: Lung cancer is the leading cause of death in the world and non-small cell lung cancer (NSCLC) accounts for approximately 85%.While, the mechanism is not fully understood. Therefore, exploring new molecules is of great significance to clarify the mechanism. Glycine decarboxylase (GLDC) is an oncogene associated with lactic acid metabolism, highly expressed in cancer stem cell-riched NSCLC. Both growth and tumorigenicity are dependent on the expression of high levels of GLDC, so which can be used as a stem cell surface marker to identify cancer stem cells. Alternative splicing (AS) is one of the important mechanisms of human gene regulation, which is closely related to the occurrence of tumor. However, the mechanism of AS regulation for GLDC in NSCLC has not been reported. Therefore, understanding the biological role of GLDC and its regulatory mechansim can lay a theoretical foundation for the early diagnosis and treatment of tumors. This experiment aims to clone human GLDC gene AS, analyze biological activity, and provide guidance for NSCLC development mechanism Method: 1.Construction of cloning vectors: Primers were designed based on the full length of GLDC (GLDCfl) and GLDC varient 1 (GLDCV1) cDNA, and mRNA expression in A549 and MRC5 cells was determined by RT-PCR combined with DNA sequencing; 2.Functional experiments:MRC5 cells were transfected with overexpression plasmids, MTT assay, plate clone, western blot, lactic acid formation assay and tumor-bearing test in vivo were used to detect MRC5 cells viability and proliferation. Result: 1.Both GLDCfl and GLDCV1 of A549 and MRC5 existed at the RNA level, the expression of which only in A549.Transfection of the target gene in MRC5 cells showed increased expression of both GLDCfl and GLDCV1. 2.GLDCfl and GLDCV1 were over-expressed in MRC5 cells, and the cell viability was increased by MTT assay. Plate clone experiments proved the proliferation of MRC5 cells, and the expression of P-ERK and P-P38 proteins on the ERK/MAPK signaling pathway were increased .The supernatants of the cells for 24 hours were collected and assayed for lactic acid, then both GLDCV1 and GLDCfl promoted lactic acid production. Meanwhile, in vivo nude mice tumor test, each 100 ml dose was inoculated subcutaneously at the back shoulder of 4-6 week old nude mouse, and the GLDCV1 group shown the tumorigenicity Conclusion: 1This study first analyzed the expression pattern of GLDC gene AS in tumor cells and revealed the biological effects in tumor cells; 2.Both GLDCV1 and GLDCfl can enhance the cell viability, promote luciferase activity, enhance cell clonal formation, and also find that GLDCV1 can enhance the tumorigenic ability. Background: Expression of programmed death-ligand 1 (PD-L1) in tumor cells plays an important role in mechanisms underlying evasion of an immune check point system. PD-L1 expression is regulated by multiple mechanisms such as the tumor microenvironment. Lung cancer tissue with increased deposition of extracellular matrix is much stiffer than normal lung tissue. There is emerging evidence that the matrix stiffness of cancer tissue affects the phenotypes and properties of cancer cells. Nevertheless, the effects of substrate rigidity on expression of PD-L1 in lung cancer cells remain elusive. This study was designed to determine whether substrate stiffness affects the regulation of PD-L1 in lung cancer cells. Method: We evaluated PD-L1 expression levels in HCC827 human lung cancer cell line. Commercially available polyacrylamide hydrogels of different stiffnesses bound to 6-well polystyrene plates or polystyrene dishes coated with type I collagen were utilized. We used 2 and 25 kPa gels as substrates of normal (soft) human lung and cancer-associated (stiff) tissue. Western blotting and Immunofluorescence staining were performed for evaluating PD-L1 expression levels. A colorimetric viability assay was performed for evaluating of PD-L1 expression and cell proliferation by using transfection with short interfering RNA (siRNA) for PD-L1. Result: Expression of PD-L1 protein was higher on the stiffer substrates (25 kPa gel and plastic dish) than on the soft 2 kPa gel. PD-L1 expression was reduced by detachment of cells adhering to the substrate. Interferon-g enhanced expression of PD-L1 protein cultured on stiff (25 kPa gel and plastic dishes) and soft (2 kPa gel) substrates and in the cell adhesionfree condition. As the stiffness of substrates increased, formation of actin stress fiber and cell growth were enhanced. Transfection of the cells with siRNA for PD-L1 inhibited cell growth without affecting stress fiber formation. Treatment of the cells with cytochalasin D, an inhibitor of actin polymerization, significantly reduced PD-L1 protein levels. Conclusion: Stiff substrates enhanced PD-L1 expression via actin cytoskeleton-dependent mechanisms in HCC827 lung cancer cell line. It is suggested that stiffness as a tumor environment regulates PD-L1 expression, which leads to evasion of the immune system and tumor growth. Keywords: microenvironment, PD-L1, mechanotransduction
